Rare & hard-to-treat diseases

Aplastic anemia, MDS & hematopoietic stem cell transplant

Hospitals in China recommended for Aplastic anemia, MDS & hematopoietic stem cell transplant, with Fudan specialty rankings and sources. Related specialties: Hematology.

Ask about this condition

General information only. It is not a diagnosis or a substitute for professional advice.

Last updated: 2026-11-03

Related specialties: Hematology
Also known as: bone marrow transplant, stem cell transplant, thalassemia

Recommended hospitals

Hospitals are listed in order of recommendation, based on the Fudan specialty reputation ranking and published sources. This is not medical advice.

1
Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences
TianjinGrade 3A Public HospitalHematology #2International patient department
National Clinical Research Center for Blood Diseases with large volume of aplastic anemia, MDS diagnosis/treatment and hematopoietic stem cell transplants, supported by national platforms for clinical research; Ranked #2 in the 2023 Fudan Hematology specialty reputation ranking
Sources: rank.cn-healthcare.com cams.ac.cn
2
Peking University People's Hospital
BeijingGrade 3A Public HospitalHematology #1International patient department
Leads in Fudan hematology ranking; Huang Xiaojun team promotes Beijing protocol for haploidentical HSCT worldwide with high transplant volume for aplastic anemia and MDS; Ranked #1 in the 2023 Fudan Hematology specialty reputation ranking
Sources: rank.cn-healthcare.com sohu.com
3
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
ShanghaiGrade 3A Public HospitalHematology #3International patient department
A++++ in Fudan hospital ranking with national key clinical specialty in hematology, mature multidisciplinary diagnosis/treatment and transplant techniques for aplastic anemia/MDS; Ranked #3 in the 2023 Fudan Hematology specialty reputation ranking
Sources: rank.cn-healthcare.com sohu.com
4
The First Affiliated Hospital of Soochow University
SuzhouGrade 3A Public HospitalHematology #4International patient department
Ranked #4 in the 2023 Fudan Hematology specialty reputation ranking
Sources: rank.cn-healthcare.com
5
Peking Union Medical College Hospital
BeijingGrade 3A Public HospitalHematology #8International patient department
National key clinical specialty in hematology, participates in national blood disease collaboration with rich experience in aplastic anemia/MDS rare disease MDT combined with transplantation; Ranked #8 in the 2023 Fudan Hematology specialty reputation ranking
Sources: rank.cn-healthcare.com pumch.cn
6
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
WuhanGrade 3A Public HospitalHematology #5International patient department
Ranked #5 in the 2023 Fudan Hematology specialty reputation ranking
Sources: rank.cn-healthcare.com

Related news

View all

Rare & hard-to-treat diseases2026-09-28

Chongqing Children's Hospital exceeds 1000 hematopoietic stem cell transplants

Chongqing Children's Hospital has exceeded 1000 hematopoietic stem cell transplants, while completing the world's highest number of 142 WAS syndrome transplants with over 90% overall PID transplant survival. The hospital pioneered several cutting-edge transplant technologies in Southwest China, including the world's first successful transplant for TYK2 gene defect disease.

Children's Hospital of Chongqing Medical University

Rare & hard-to-treat diseases2025-09-16

Three-Year Milestone! First Pediatric Hematopoietic Stem Cell Transplant Patient at Xiangya Third Hospital Recovers and 'Graduates'

The pediatric team independently completed the hospital's first pediatric haploidentical allogeneic hematopoietic stem cell transplant for a child with extremely severe aplastic anemia. After three years of follow-up the patient met clinical cure standards, with the team's nearly 30 pediatric cases achieving a 96% success rate.

The Third Xiangya Hospital of Central South University

Rare & hard-to-treat diseases2026-10-13

1,000 Transplants Over 19 Years: Rebuilding Immune Barriers for Children Born Without Protection

The hospital has performed over 1,000 hematopoietic stem cell transplants, becoming western China's largest pediatric transplant center. It achieved an overall survival rate exceeding 90% in 352 PID cases, completed the world's first TYK2 gene defect transplant with cure, and leads globally with 142 WAS transplants at a single center.

Children's Hospital of Chongqing Medical University

Oncology2025-09-05

World's First Allogeneic Artificial Regenerated Platelet Clinical Study Succeeds in Shanghai

Shanghai Children's Medical Center completed the world's first iPLT clinical infusion study, transfusing patients with acute leukemia, aplastic anemia, and post-operative complex congenital heart disease, preliminarily confirming safety and good tolerability.

Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine